Fig. 8From: Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncologySPECT/CT images of a PC-3 tumor-bearing mouse, at a 4 h and b 24 h pi of [111In]In-AU-SAR-M1, red arrows indicate tumor-sitesBack to article page